Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The merger ...
Big Tech lobbies EU, Oracle shifts, OpenAI evolves | Ep. 13 In today’s Tech Briefing: Big Tech outspends entire industries lobbying the European Union, with Meta leading a €151 million push to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback